The purpose of this task order is the development and delivery of a quality assurance/quality control (QA/QC) plan and participation in the task order initiation meeting.
Ended Awarded Last action
- Contract number
- 75N93021F00002
- Awardee
-
Lovelace Biomedical Research Institute UEI MBT9RXJJ7428
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $18,397
Award facts
- Opportunity
-
- Preclinical Services for HIV Therapeutics Pre-Solicitation · 75N93021F00002 · Posted Oct 4, 2019
- Contract value 100% obligated
- $18,397.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albuquerque, NM 87108, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$497 | |
| Original award | $18,894 |
About this award
The Lovelace Biomedical Research Institute was awarded a $18,397 cost plus fixed fee delivery order against the Preclinical Services for HIV Therapeutics master indefinite-delivery/indefinite-quantity contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The purpose of this task order is for Lovelace to develop and deliver a quality assurance/quality control plan and participate in a task order initiation meeting to support preclinical services under the HIV Therapeutics IDIQ. Work will be performed in Albuquerque, New Mexico through August 2021. No set aside designation or subcontractors were indicated. This delivery order provides specialized preclinical research support to NIH's efforts advancing HIV/AIDS treatments.
Quick answers
Who was awarded contract 75N93021F00002?
75N93021F00002 was awarded to Lovelace Biomedical Research Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 15, 2021.
How much is contract 75N93021F00002 worth?
The government has obligated $18,397 on 75N93021F00002.
Is contract 75N93021F00002 an order under another contract?
Yes. 75N93021F00002 is a delivery order under 75N93021D00007, an indefinite delivery contract, on Preclinical Services for HIV Therapeutics.
Was contract 75N93021F00002 competed?
The extent of competition for 75N93021F00002 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award